Skip to main content
Download PDF

Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study

BMC Cancer volume 21, Article number: 1191 (2021) Cite this article

The Original Article was published on 14 September 2021

Correction to: BMC Cancer 21, 1021 (2021)

https://doi.org/10.1186/s12885-021-08738-z

Following publication of the original article [1], the authors identified an error in the author names of Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen and Chandrasekhar Chikatapu. The given names and family names were erroneously transposed.

Further to this, figure 1 has been updated. The line colors in “C” section for “Poor” and “Unknown” have been changed to align with Figure B and legend to match the line colors.

The author group has been updated above and the original article [1] has been corrected.

Fig. 1
figure 1

Kaplan-Meier plot for PFS for (A) all patients, (B) MSKCC risk categories, and (C) IMDC risk categories (FAS)

Full size image

Reference

  1. Erman M, Biswas B, Danchaivijitr P, et al. Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study. BMC Cancer. 2021;21(1):1021. https://doi.org/10.1186/s12885-021-08738-z.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Oncology, Hacettepe University, Ankara, Turkey

    Mustafa Erman

  2. Medical Oncology, Tata Medical Center, Kolkata, West Bengal, India

    Bivas Biswas

  3. Medical Oncology, Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Pongwut Danchaivijitr

  4. Medical Oncology, The First Affiliated Hospital of Sun Yat-sen, Guangzhou, Guangzhou, Guangdong Province, China

    Lingwu Chen

  5. Radiotherapy and Oncology, National Cancer Institute, Putrajaya, Malaysia

    Yoke Fui Wong

  6. Medical Oncology, Dr. Tarek Hashem’s Clinic, Cairo, Egypt

    Tarek Hashem

  7. Clinical Oncology, Sultan Ismail Hospital, Johor Bahru, Malaysia

    Chun Sen Lim

  8. Medical Oncology, Ege University, Izmir, Turkey

    Bulent Karabulut

  9. Department of Urology, Taipei Veterans General Hospital and Department of Urology, College of Medicine and Shu-Tien Urological Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Hsiao-Jen Chung

  10. Oncology, Novartis Healthcare Pvt. Ltd., Hyderabad, Telangana, India

    Chandrasekhar Chikatapu

  11. Oncology, Novartis Pharma AG, Basel, Switzerland

    Sara Ingles

  12. Oncology, Novartis Pharma SAS, Rueil-Malmaison, France

    Khemaies Slimane

  13. Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore

    Ravindran Kanesvaran

Authors
  1. Mustafa Erman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bivas Biswas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pongwut Danchaivijitr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lingwu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoke Fui Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tarek Hashem
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chun Sen Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bulent Karabulut
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hsiao-Jen Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Chandrasekhar Chikatapu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sara Ingles
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Khemaies Slimane
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Ravindran Kanesvaran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ravindran Kanesvaran.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erman, M., Biswas, B., Danchaivijitr, P. et al. Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study. BMC Cancer 21, 1191 (2021). https://doi.org/10.1186/s12885-021-08848-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12885-021-08848-8

BMC Cancer

ISSN: 1471-2407

Contact us